{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T16:29:52Z","timestamp":1750955392983,"version":"3.41.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Pituitary carcinomas are extremely rare and aggressive tumors that comprise only 0.2% of all pituitary tumors. Because of its rarity, pituitary carcinomas are difficult to diagnose. Conventional imaging methods are inadequate to detect metastatic lesions. Pituitary carcinomas are neuroendocrine tumors and express somatostatin receptors; therefore, <jats:sup>68<\/jats:sup>Ga-DOTATATE PET\/CT may be used in the staging of these rare tumors. Herein, we present an exceptional case of pituitary carcinoma with sclerotic skeletal metastases showing <jats:sup>68<\/jats:sup>Ga-DOTATATE uptake.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004029","type":"journal-article","created":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T20:18:47Z","timestamp":1642105127000},"page":"e298-e299","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["A Rare Case of Pituitary Carcinoma With Bone Metastases"],"prefix":"10.1097","volume":"47","author":[{"given":"Nuh","family":"Filizoglu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salih","family":"Ozguven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,1,13]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s11102-018-0872-8","article-title":"Corticotrophic pituitary carcinoma with cervical metastases: case series and literature review","volume":"21","year":"2018","journal-title":"Pituitary"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.wneu.2020.03.154","article-title":"Metastatic pituitary carcinoma causing cord compression","volume":"139","year":"2020","journal-title":"World Neurosurg"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11102-017-0857-z","article-title":"Malignant transformation in non-functioning pituitary adenomas (pituitary carcinoma)","volume":"21","year":"2018","journal-title":"Pituitary"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2967\/jnumed.109.066134","article-title":"The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy","volume":"51","year":"2010","journal-title":"J Nucl Med"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/RLU.0000000000000589","article-title":"The use of (68) Ga DOTATATE PET\/CT for diagnostic assessment and monitoring of (177) Lu DOTATATE therapy in pituitary carcinoma","volume":"40","year":"2015","journal-title":"Clin Nucl Med"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/RLU.0000000000003589","article-title":"68Ga-DOTATATE PET\/CT imaging of refractory pituitary macroadenoma invading the orbit","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4103\/sni.sni_498_16","article-title":"Pituitary carcinoma: a case report and discussion of potential value of combined use of Ga-68 DOTATATE and F-18 FDG PET\/CT scan to better choose therapy","volume":"8","year":"2017","journal-title":"Surg Neurol Int"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1097\/RLU.0000000000000462","article-title":"Improvement in diagnosis of metastatic pituitary carcinoma by 68Ga DOTATATE PET\/CT","volume":"40","year":"2015","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:07:04Z","timestamp":1750536424000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004029"}},"subtitle":["68Ga-DOTATATE PET\/CT Findings"],"short-title":[],"issued":{"date-parts":[[2022,1,13]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004029","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2022,1,13]]}}}